CUBE vs VIR · P/E 25, rev $1.07B vs rev $74.2M
CubeSmart (CUBE) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. VIR currently screens at market cap $1.45B.
Not investment advice. Open the CUBE and VIR stock pages for the full models.
Not investment advice.